ALDEYRA THERAPEUTICS INC (ALDX) Stock Cash Flow
NASDAQ:ALDX - Nasdaq - US01438T1060 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -57.70M | -55.85M | -37.54M | -62.02M | -57.78M | |||
| Depreciation Amortization | 249.90K | 249.60K | 262.80K | 260.00K | 260.00K | |||
| Income Taxes - Deferred | N/A | N/A | N/A | N/A | 0.00 | |||
| Change In Working Capital | 4.55M | 5.91M | 861.20K | -3.44M | 7.44M | |||
| Interest Paid | 1.73M | 1.75M | 1.70M | 1.34M | 1.34M | |||
| Other non cash items | 7.19M | 6.48M | 6.09M | 8.57M | 7.52M | |||
| OPERATING CASH FLOW | -45.71M | -43.21M | -30.33M | -56.64M | -42.56M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | N/A | 0.00 | -20.00K | -10.00K | |||
| Other Investing Activity | -7.25M | -44.92M | 30.00M | -29.94M | 0.00 | |||
| INVESTING CASH FLOW | -7.25M | -44.92M | 30.00M | -29.95M | -10.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | -292.50K | -1.04M | N/A | N/A | |||
| Stock Issued/Repurchased | N/A | 83.00K | 194.10K | 1.12M | 194.43M | |||
| Other Financing Activity | 39.50K | 38.10K | -421.90K | 100.00K | 60.00K | |||
| FINANCING CASH FLOW | 813.20K | -171.40K | -1.27M | 1.22M | 194.50M | |||
| CHANGE IN CASH | -52.14M | -88.30M | -1.60M | -85.37M | 151.93M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -45.71M | -43.21M | -30.33M | -56.64M | -42.56M | |||
| Capital Expenditure | N/A | N/A | 0.00 | -20.00K | -10.00K | |||
| FREE CASH FLOW | -45.71M | -43.21M | -30.33M | -56.66M | -42.57M | |||
All data in USD